Day-2 serum progesterone level and IVF/ICSI outcome: a comparative study


  • Akshaya Kumar Mahapatro Department of Reproductive Medicine, Madras Medical Mission, Chennai, Tamilnadu, India
  • Abhishek Radhakrishan Department of Reproductive Medicine, Madras Medical Mission, Chennai, Tamilnadu, India



Clinical pregnancy, Gonadotrophins GnRH antagonist, Intracytoplasmic sperm injection, Live birth, Progesterone


Background: Purpose of this study was to evaluate the in vitro fertilisation outcome in patients having normal or elevated day-2 serum progesterone level undergone IVF by using GnRH antagonist.

Methods: A retrospective study conducted in Institute of Reproductive Medicine, Chennai during January 2013 to March 2014. According to patient’s Day-2 serum progesterone level the total no of cases (N=151) were divided into two groups group-1 (N=116) with progesterone value ≤1.5ng/ml and group-2 (N=35) with progesterone value>1.5ng/ml. Ovarian stimulation was started with recombinant FSH on day 2 and GnRH antagonist injections started from day 6 of stimulation. Total dose of gonadotropins, days of gonadotrophin injections, no of eggs collected, Clinical pregnancy rate and live birth rate were compared between two groups.

Results: Two groups were similar with regards to age, BMI, days of gonadotrophins and total doses of gonadotrophins. Incidence of elevated P level was 23.17%. Total pregnancy rate was 36.42%. A non-statistically-significant difference was observed in clinical pregnancy (37.06% vs 34.28%) and live birth (32.75% vs 28.57%) between the normal and elevated progesterone groups.

Conclusions: Elevated day-2 serum progesterone level   was associated with lower clinical pregnancy rate but it was not statistically-significant.


Huang JC, Jackson KV, Hornstein MD, Ginsburg ES. The effect of elevated serum progesterone during ovulation induction in invitro fertilization embryo transfer. J Assist Reprod Genet. 1996;13:617-24.

Hugues JN, Cedrin-Durnerin I. Endocrine characteristics of ART cycles. IN: Gardner DK, WEissman A, HOWles CM, Shoham Z (Eds). Text Book of Assisted Reproductive Techologies: laboratory and clinical perspectives, 3rd edition. London, UK: Informa Healthcare;2009:511-28.

Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC et al. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Hum Reprod. 2004;19:1525-9.

Blockeel C, BaumgartenM, De VosM, Verheyen G, Devroey P. Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study. Curr Pharm Biotechnol. 2011;12:423-8.

Hamdine O, Broekmans FJ, Eijkemans MJ, Lambalk CB, Fauser BC, Laven JS et al. Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6. Fertil Steril. 2013;100:867-74.

Loumaye E.,Vankrieken L,Depreester S,et al .Hormonal changes induced by short –term administration of Gonadotrophin releasing hormone agonist during ovarian hyper stimulation for invitrofertilisation and their consequences for embryo development. Fertil Steril. 1989;51:105-11.

Brzyski RG, Muasher SJ, Droesch K, Simonetti S, Jones GS, Rosenwaks Z. Follicular atresia associated with concurrent intiation of GnRH agonist and FSH for oocyte recruitment. Fertil Steril. 1988;50:917-21.

Sims JA, Seltman HJ, Muasher SJ. Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotropin releasing hormone agonist impairs follicular recruitment for in-vitro fertilization. Hum Reprod. 1994;9:235-40.

De Geyter C, De Geyter M, Huber PR, Nieschlag E, Holzgreve W. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Hum Reprod. 2002;17:933-9.

Keck C, Neulen J, Breig-Lauel S, Breckwoldt M. Elevated serum progesterone concentrations during the early follicular phase of the menstrual cycle: clinical significance and therapeutic implications. Gynecol Endocrinol. 1999;13:161-5.

van Zonneveld P, Scheffer GJ, Broekmans FJ, Blankenstein MA, de Jong FH, Looman CW et al. Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women. Hum Reprod. 2003;18:495-501.

Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A et al. Comparison of early versus late initiation of GnRH antagonist cotreatment for controlled ovarian stimulation in IVF: a randomized controlled trial. Hum Reprod. 2013;28:3227-35.

Hamdine O, Macklon NS, Eijkemans MJC, Laven JSE, Cohlen BJ. Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis. Fertil Steril. 2014;102(2):448-54.






Original Research Articles